{"id":"NCT01964989","sponsor":"Seqirus","briefTitle":"Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.","officialTitle":"A Phase III, Stratified, Randomized, Observer Blind, Controlled, Multicenter Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to < 72 Months of Age.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2015-10","completion":"2016-08","firstPosted":"2013-10-17","resultsPosted":"2023-03-27","lastUpdate":"2023-03-27"},"enrollment":10644,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza Virus"],"interventions":[{"type":"BIOLOGICAL","name":"Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)","otherNames":[]},{"type":"BIOLOGICAL","name":"Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)","otherNames":[]}],"arms":[{"label":"aQIV","type":"EXPERIMENTAL"},{"label":"non-adjuvanted comparator","type":"ACTIVE_COMPARATOR"}],"summary":"Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children ≥6 to \\<72 Months of Age. The study was conducted during the 2013/2014 and 2014/2015 northern hemisphere influenza season.","primaryOutcome":{"measure":"Efficacy Endpoint: First-Occurrence Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Confirmed Influenza A and/or B of Any Influenza Strain in Subjects ≥6 to <72 Months of Age","timeFrame":"≥21 days and ≤180 days after the last vaccination or until the end of the influenza season (Northern Hemisphere: end of June; Southern Hemisphere: end of December; Philippines/Thailand: end of October), whichever was longer","effectByArm":[{"arm":"aQIV (≥6 to <72 Months)","deltaMin":256,"sd":null},{"arm":"TIV/QIV (≥6 to <72 Months)","deltaMin":252,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":167,"countries":["United States","Canada","Finland","Italy","Mexico","Philippines","Poland","Puerto Rico","Spain","Taiwan","Thailand"]},"refs":{"pmids":["32404782","29631857"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":234,"n":5243},"commonTop":["Influenza like illness","Injection site pain","Irritability","Somnolence","Injection site erythema"]}}